|1|Chronic kidney disease in patients with renal cell carcinoma. (24359991)
Chang A.... Rosner M.
|2|Is uremic cardiomyopathy a direct consequence of chronic kidney disease? (24404903)
Chinnappa S.... Tan L.B.
|3|Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease. (24291534)
Diwan V.... Brown L.
|4|Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease. (24048375)
Kogon A.J.... Flynn J.T.
|5|Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study. (22467089)
Yap Y.S.... Liu Y.C.
|6|WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients. (24223203)
Mizushima D.... Oka S.
|7|Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. (23085781)
Ozkok A.... Ecder T.
|8|Risk of Sudden Cardiac Death in Chronic Kidney Disease. (24256575)
Poulikakos D.... Malik M.
|9|Rutin (quercetin rutinoside) induced protein-energy malnutrition in chronic kidney disease, but quercetin acted beneficially. (23876017)
Hsieh C.L.... Peng R.Y.
|10|A continuous bovine kidney cell line constitutively expressing bovine I+vI^6 integrin has increased susceptibility to foot-and-mouth disease virus. (23515553)
LaRocco M.... Rodriguez L.L.
|11|Genetics in kidney disease in 2013: Susceptibility genes for renal and urological disorders. (24296626)
Divers J.... Freedman B.I.
|12|Statins in chronic kidney disease: what do meta-analyses tell us? (24158229)
|13|Pre-eclampsia and the risk of kidney disease. (23727168)
|14|Peritransplant management of retained native kidneys in autosomal dominant polycystic kidney disease. (22773241)
|15|Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study. (23982888)
|16|New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study. (21854501)
Ruderman I.... Walker R.G.
|17|Prevention of chronic kidney disease in spina bifida. (21229390)
Filler G.... Dave S.
|18|Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease. (22017187)
Abbiss H.... Trengove R.D.
|19|Impact of chronic kidney disease on outcomes after abdominal aortic aneurysm repair. (22857808)
Patel V.I.... Cambria R.P.
|20|The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease. (22499140)
|21|Animal models for human polycystic kidney disease. (23095811)
Nagao S.... Yamaguchi T.
|22|Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome. (21972098)
|23|Altered Hippo signalling in polycystic kidney disease. (21381034)
HappAc H.... Peters D.J.
|24|Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. (20881939)
Reed B.Y.... Schrier R.W.
|25|Anesthetic considerations in a patient of autosomal dominant polycystic kidney disease on hemodialysis for emergency cesarean section. (21897520)
Fernandes S.D.... Suvarna D.
|26|Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications? (20503017)
|27|One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis. (20438515)
|28|Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. (20200094)
Finch J.L.... Slatopolsky E.
|29|Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. (20091490)
Chitalia N.... Banerjee D.
|30|Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. (19955044)
Cash H.... Schwarting A.
|31|Chronic kidney disease with three cases of oxalate-like nephrosis in Ragdoll cats. (19095478)
Heiene R.... Ottesen N.
|32|Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. (19470766)
Beroukhim R.... Signoretti S.
|33|Recurrent retroperitoneal abscess due to perforated colonic diverticulitis in a patient with polycystic kidney disease. (19299224)
Li S.Y.... Ng Y.Y.
|34|Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus. (19288030)
Yoshida T.... Yamada Y.
|35|Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan. (19059824)
Chen W.... Chuang F.R.
|36|Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. (18981227)
Jonassen J.A.... Pazour G.J.
|37|Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient. (18489645)
Nishihara K.... Ito H.
|38|A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. (18094682)
Fouque D.... Wanner C.
|39|Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. (19060482)
ReiterovA! J.... Tesar V.
|40|Osteopontin (OPN), PDGF-BB (platelet-derived growth factor) and BMP-7 (bone morphogenetic protein) as markers of atherogenesis in children with chronic kidney disease (CKD) treated conservatively--preliminary results]. (18924496)
MusiaA8 K.... ZwoliA8ska D.
|41|PKHD1 gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease. (17669261)
Yang J.... Xiao C.
|42|Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. (17035608)
Eddy A.A.... Fogo A.B.
|43|Risks of chronic metabolic acidosis in patients with chronic kidney disease. (15882309)
Kopple J.D.... Mehrotra R.
|44|Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. (16032613)
Han J.H.... Gibler W.B.
|45|An unexpected cystic kidney and pancreas disease. (12032212)
Kuzmanovska D.... Naumovski S.
|46|AT(1)-receptor blockade and the kidney: importance of non-ACE pathways in health and disease. (12140730)
|47|Confirmation of a gene locus for medullary cystic kidney disease (MCKD2) on chromosome 16p12. (11576337)
Hateboer N.... Rahman N.
|48|Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. (10880400)
Andrews K.L.... Miner J.H.
|49|A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). (9326320)
Veldhuisen B.... Peters D.J.M.
|50|A role for CFTR in human autosomal dominant polycystic kidney disease. (8772467)
Hanaoka K.... Guggino W.B.